This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bobkov, A. F.
Right arrow Articles by Rylkov, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bobkov, A. F.
Right arrow Articles by Rylkov, A. V.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2005, p. 1937-1939, Vol. 43, No. 4
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.4.1937-1939.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus Type 1 in Illicit-Drug Solutions Used Intravenously Retains Infectivity

Aleksei F. Bobkov,1* Ludmila M. Selimova,1 Tatyana A. Khanina,1 Sergey Y. Zverev,2 Vadim V. Pokrovsky,3 Jonathan N. Weber,4 Eugene N. Bobkov,5 and Andrey V. Rylkov5

The D. I. Ivanovsky Institute of Virology,1 Federal AIDS Centre,3 AIDS Foundation East-West (AFEW), Moscow,5 Perm Regional AIDS Centre, Perm, Russian Federation,2 Wright-Fleming Institute, Imperial College London, United Kingdom4

Received 10 February 2004/ Returned for modification 15 May 2004/ Accepted 27 November 2004

The stability of the human immunodeficiency virus type 1 (HIV-1) strain IIIB in drug solutions was studied. The data demonstrate that HIV-1 infectivity can be retained in drug solutions (e.g. , heroin, "Khanka," and "Vint") for long periods of time. This fact must be taken into account when designing health education programs for the prevention of HIV and AIDS in Eastern Europe.


* Corresponding author. Mailing address: The D. I. Ivanovsky Institute of Virology, Moscow, Russian Federation. Phone: 7 095 190 2850. Fax: 7 095 190 2867. E-mail: a.bobkov{at}mail.ru.


Journal of Clinical Microbiology, April 2005, p. 1937-1939, Vol. 43, No. 4
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.4.1937-1939.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.